Beyond Air Management
Management criteria checks 3/4
Beyond Air's CEO is Steve Lisi, appointed in Jun 2017, has a tenure of 7.42 years. total yearly compensation is $1.73M, comprised of 37.5% salary and 62.5% bonuses, including company stock and options. directly owns 4.5% of the company’s shares, worth $1.69M. The average tenure of the management team and the board of directors is 2.3 years and 7 years respectively.
Key information
Steve Lisi
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 37.5% |
| CEO tenure | 7.4yrs |
| CEO ownership | 4.5% |
| Management average tenure | 2.3yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate
Apr 05
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?
Dec 14Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak
Oct 17Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay
Sep 08Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy
Aug 23Beyond Air reaches six-month high after $2.3M insider transactions
Jul 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$55m |
| Jun 30 2024 | n/a | n/a | -US$58m |
| Mar 31 2024 | US$2m | US$650k | -US$60m |
| Dec 31 2023 | n/a | n/a | -US$67m |
| Sep 30 2023 | n/a | n/a | -US$63m |
| Jun 30 2023 | n/a | n/a | -US$59m |
| Mar 31 2023 | US$7m | US$650k | -US$56m |
| Dec 31 2022 | n/a | n/a | -US$56m |
| Sep 30 2022 | n/a | n/a | -US$51m |
| Jun 30 2022 | n/a | n/a | -US$47m |
| Mar 31 2022 | US$6m | US$450k | -US$43m |
| Dec 31 2021 | n/a | n/a | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$26m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | US$2m | US$450k | -US$23m |
| Dec 31 2020 | n/a | n/a | -US$23m |
| Sep 30 2020 | n/a | n/a | -US$22m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | US$1m | US$450k | -US$20m |
| Dec 31 2019 | n/a | n/a | -US$15m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$11m |
| Mar 31 2019 | US$3m | US$450k | -US$7m |
| Dec 31 2018 | n/a | n/a | -US$5m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$10m |
| Mar 31 2018 | US$537k | US$130k | -US$11m |
| Dec 31 2017 | US$2m | US$163k | -US$18m |
Compensation vs Market: Steve's total compensation ($USD1.73M) is above average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
CEO
Steve Lisi (53 yo)
7.4yrs
Tenure
US$1,733,000
Compensation
Mr. Steven Adam Lisi, also known as Steve, has been the Chief Executive Officer of Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.) since June 14, 2017. Mr. Lisi serves as Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 7.4yrs | US$1.73m | 4.5% $ 1.7m | |
| Chief Operating Officer | 2.3yrs | US$799.00k | 0.090% $ 33.8k | |
| Chief Executive Officer of NeuroNOS | less than a year | US$952.00k | 0% $ 0 | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 3.2yrs | US$1.13m | 0.026% $ 9.6k | |
| Head of Investor Relations | no data | no data | no data | |
| Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Head of Research & Clinical Development | less than a year | no data | no data | |
| Corporate Secretary | no data | US$643.57k | no data |
2.3yrs
Average Tenure
54yo
Average Age
Experienced Management: XAIR's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 7.8yrs | US$1.73m | 4.5% $ 1.7m | |
| Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | 11.8yrs | no data | no data | |
| Independent Director | 6.8yrs | US$51.30k | 0.018% $ 6.6k | |
| Independent Director | 5.8yrs | US$102.60k | 6.31% $ 2.4m | |
| Independent Director | 7.8yrs | US$51.30k | 0.20% $ 75.2k | |
| Independent Director | 6.3yrs | US$51.30k | 0.021% $ 7.7k | |
| Member of Scientific Advisory Board | 6.8yrs | US$75.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 7.3yrs | US$51.30k | 0.060% $ 22.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.0yrs
Average Tenure
60yo
Average Age
Experienced Board: XAIR's board of directors are considered experienced (7 years average tenure).